Clinical Trials on Refractory Lymphoplasmacytic Lymphoma in Korea, Republic of
Total 895 results
-
Samsung Medical CenterCompletedRelapsed or Refractory Peripheral T-cell LymphomaKorea, Republic of
-
Seoul National University HospitalSeoul National University Bundang Hospital; SMG-SNU Boramae Medical CenterCompletedRelapsed or Refractory EBV-and CD30-positive LymphomasKorea, Republic of
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Follicular Lymphoma or Mantle Cell LymphomaKorea, Republic of
-
GC Cell CorporationUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaKorea, Republic of
-
Seoul National University HospitalSeoul National University Bundang HospitalUnknownWaldenstrom Macroglobulinemia | Lymphoplasmacytic LymphomaKorea, Republic of
-
TakedaCompletedClassical Hodgkin Lymphoma | Relapsed or Refractory Classical Hodgkin LymphomaKorea, Republic of
-
Seoul National University HospitalRecruitingRelapsed/Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
Seoul National University HospitalNot yet recruitingDiffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaKorea, Republic of
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Marginal Zone B-cell LymphomaKorea, Republic of
-
GI Cell, Inc.RecruitingAdvanced Solid Tumors | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Non-Hodgkin LymphomaKorea, Republic of
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
IGM Biosciences, Inc.No longer availableRelapsed/Refractory Non-Hodgkin LymphomasAustralia, Korea, Republic of, Spain
-
Curocell Inc.RecruitingHigh-grade B-cell Lymphoma | Diffuse Large B-cell Lymphoma (DLBCL) | Primary Mediastinal Large B-Cell Lymphoma (PMBCL) | Transformed Follicular Lymphoma (TFL) | Refractory Large B-cell Lymphoma | Relapsed Large B-cell LymphomaKorea, Republic of
-
Won Seog KimSanofiRecruitingNatural Killer/T-cell Lymphoma | Relapsed Natural Killer/T-cell Lymphoma | Refractory Natural Killer/T-cell LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedPrimary Mediastinal Large B-cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedRelapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin LymphomaKorea, Republic of
-
National Cancer Center, KoreaRecruitingRelapsed/Refractory Classical Hodgkin LymphomaKorea, Republic of
-
Dong-A University HospitalSamsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaboratorsCompletedB-cell LymphomasKorea, Republic of
-
Samsung Medical CenterCompletedRelapsed and/or Refractory Cutaneous T-cell LymphomaKorea, Republic of
-
Samsung Medical CenterJanssen Medical AffairsCompletedNon-Hodgkin Lymphoma | Peripheral T-Cell LymphomasKorea, Republic of
-
Samsung Medical CenterRecruitingRelapsed and/or Refractory Non-Hodgkin T-cell LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterWithdrawnRefractory Solid TumorsKorea, Republic of
-
Ajou University School of MedicineUnknownLymphoblastic LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedRefractory CancerKorea, Republic of
-
Samsung Medical CenterRecruitingPeripheral T-cell LymphomaKorea, Republic of
-
Samsung Medical CenterUnknownExtranodal NK-T-Cell LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Seoul National University HospitalGC Biopharma CorpCompletedSolid Tumors | Malignant LymphomasKorea, Republic of
-
Samsung Medical CenterUnknownRefractory CancerKorea, Republic of
-
Samsung Medical CenterCompletedHER2-positive Refractory Advanced CancerKorea, Republic of
-
Asan Medical CenterEli Lilly and CompanyTerminatedNon-Hodgkin's Lymphoma | Marginal Zone LymphomaKorea, Republic of
-
Chonbuk National University HospitalSamsung Medical Center; Pusan National University Hospital; Chonnam National... and other collaboratorsCompletedAngioimmunoblastic T-cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Anaplastic Large Cell Lymphoma, ALK-negativeKorea, Republic of
-
Asan Medical CenterTerminatedLymphoblastic Lymphoma | Leukemia, Biphenotypic, Acute | Leukemia, Acute Lymphoblastic | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Precursor B-Cell Lymphoblastic LeukemiaKorea, Republic of
-
Samsung Medical CenterMinistry of Health, Republic of KoreaRecruitingRelapsed Pediatric AML | Refractory Pediatric AML | Relapsed Pediatric Solid Tumor | Refractory Pediatric Solid TumorKorea, Republic of
-
Samsung Medical CenterConsortium for Improving Survival of Lymphoma; Lymphoma Study Association; Deok-Hwan... and other collaboratorsCompletedExtranodal NK/T-cell Lymphoma, Nasal TypeKorea, Republic of
-
Asan Medical CenterTerminatedAcute Lymphoid LeukemiaKorea, Republic of
-
Asan Medical CenterUnknownDiffuse Large B-cell LymphomaKorea, Republic of
-
Chonbuk National University HospitalConsortium for Improving Survival of LymphomaCompletedLarge B Cell Diffuse LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedDiffuse Large B-cell Lymphoma (DLBCL)Korea, Republic of
-
Samsung Medical CenterCompletedExtranodal NK/T Cell LymphomaKorea, Republic of
-
Samsung Medical CenterMinistry of Health, Republic of KoreaNot yet recruitingRelapsed Pediatric Solid Tumor | Refractory Pediatric Solid TumorKorea, Republic of
-
Won Seog KimRecruitingLymphomaKorea, Republic of
-
Samsung Medical CenterJanssen, LPUnknown
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Severance HospitalCompletedNK/T-cell Lymphoma of Nasal CavityKorea, Republic of
-
Asan Medical CenterWithdrawnDiffuse Large B-cell LymphomaKorea, Republic of